Viatris (VTRS) returns

Pharmaceuticals · NASDAQ · Health Care

$19.04 -0.86% Close Oct 30, 2026 Live

Viatris returns over 5 years

$1,000 invested in Viatris five years ago was worth $1,759 at the close on October 30, 2026, with dividends reinvested: an average return of 12.0% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.

VTRS, $10,000 investedS&P 500 (SPY)
$10,000$20,000
202120222023202420252026

Total return by period

With dividends reinvested, to the close on Oct 30, 2026. A year means 365 days.
PeriodTotal returnA year, on average$1,000 becameS&P 500 (SPY)
1 month +7.4% — $1,074 -0.9%
3 months +8.0% — $1,080 +2.1%
Year to date +56.4% — $1,564 +11.7%
1 year +90.1% — $1,901 +12.4%
3 years +144.1% +34.6% $2,441 +88.5%
5 years +75.9% +12.0% $1,759 +76.0%

Viatris return by calendar year

YearVTRSS&P 500 (SPY)Difference
2026 to date +56.4% +11.7% +44.7%
2025 +5.1% +17.7% -12.6%
2024 +19.7% +24.9% -5.2%
2023 +2.1% +26.2% -24.1%
2022 -14.3% -18.2% +3.9%
2021 -26.1% +28.7% -54.9%

Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.

See also: VTRS financials

No forecast, no recommendation. This page describes Viatris from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.